Literature DB >> 22366680

Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin-angiotensin-aldosterone system in rats.

You Mee Ahn1, Kyung Woo Cho, Dae Gill Kang, Ho Sub Lee.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Oryeongsan (ORS, Wulingsan), a formula composed of five herbal medicines, has long been used for the treatment of impairments of the regulation of body fluid homeostasis in China, Japan and Korea. AIM OF THE STUDY: The purpose of the present study was to test the effects of ORS on the renal function and the mechanisms involved in rats.
MATERIALS AND METHODS: Experiments were performed in rats caged individually. Renal function and plasma levels of renin activity and aldosterone concentration were measured.
RESULTS: Treatment of ORS resulted in increases in urinary volume, excretion of Na(+), K(+), and Cl(-), and glomerular filtration rate, and decreases in urinary osmolality and Na(+) balance. Further, ORS decreased plasma renin activity and aldosterone concentration. An increase in urinay excretion of Na(+) was a function of glomerular filtration rate, while the increase in the day-time period was related with the increase in the ratio of urinary Na(+)/K(+).
CONCLUSION: Therefore, the present results suggest that ORS induces diuresis and natriuresis via inhibition of the renin-angiotensin-aldosterone system in rats.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366680     DOI: 10.1016/j.jep.2012.02.021

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

Review 1.  Herbal nutraceutical treatment of chronic prostatitis-chronic pelvic pain syndrome: a literature review.

Authors:  Ochbayasakh Dashdondov; Junaid Wazir; Ganbolor Sukhbaatar; Reyaj Mikrani; Buyankhishig Dorjsuren; Nasrin Aktar; Xiaohui Zhou
Journal:  Int Urol Nephrol       Date:  2021-04-27       Impact factor: 2.370

2.  Evaluation of the safety and adverse effects of goreisan/wulingsan, a traditional Japanese-chinese herbal formulation (kampo), in a rat model: a toxicological evaluation.

Authors:  Selim Ahmed; Ryuichi Uchida; Maleeha Hussain; Arm Luthful Kabir; Mohammed Zakiur Rahman; Mohammad Sharifur Rahman; Sumihisa Honda; Mohammad Abdur Rashid
Journal:  Trop Med Health       Date:  2014-07-12

3.  Oryeongsan inhibits LPS-induced production of inflammatory mediators via blockade of the NF-kappaB, MAPK pathways and leads to HO-1 induction in macrophage cells.

Authors:  You-Chang Oh; Yun Hee Jeong; Jeong-Ho Ha; Won-Kyung Cho; Jin Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2014-07-14       Impact factor: 3.659

4.  Efficacy and safety of Wuling San for treatment of breast-cancer-related upper extremity lymphoedema: study protocol for a pilot trial.

Authors:  Huiru Zhu; Zheng Peng; Meiyu Dai; Yan Zou; Fengxian Qin; Jifei Chen; Liuying Song; Baoyu He; Xiaolan Lv; Shengming Dai
Journal:  BMJ Open       Date:  2016-12-16       Impact factor: 2.692

5.  Successful treatment of refractory edema with traditional herbal medicine: A case report.

Authors:  Gayoung Lee; Jung-Hyo Cho; Chang-Gue Son; Namhun Lee
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

6.  Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis.

Authors:  Rino Inada; Katsuichi Miyamoto; Noriko Tanaka; Kota Moriguchi; Susumu Kusunoki
Journal:  Intern Med       Date:  2019-09-03       Impact factor: 1.271

7.  Antihypertensive and Renal Protective Effects of Oryeongsan in Spontaneously Hypertensive Rats.

Authors:  Kiwan Kang; Minjeong Jeong; Hongjun Kim; Beomjin Lim; Sangjun Kim; Insoo Jang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-21       Impact factor: 2.629

8.  The efficacy and safety of Wulingsan modified formulas for chronic heart failure patients: a systematic review and meta-analysis.

Authors:  Ziyun Li; Lang Ren; Renjun Gu; Conghui Zhou; Xu Tong; Jingqing Hu
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

9.  Amelioration of Hypertension by Oryeongsan through Improvements of Body Fluid and Sodium Balance: Roles of the Renin-Angiotensin System and Atrial Natriuretic Peptide System.

Authors:  You Mee Ahn; Hye Yoom Kim; Jung Joo Yoon; Hyun Ju Kim; Yun Jung Lee; Young Gab Yun; Hyeun Kyoo Shin; Kyung Woo Cho; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

10.  Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway.

Authors:  Yan-Ni Wang; Hong-Jiao Liu; Li-Li Ren; Ping Suo; Liang Zou; Ya-Mei Zhang; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.